The diagnosis of Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 1, Issue 4-5, 1999, Pages 249-263

  Villareal, D T ^a   Morris, J C ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Age related cognitive decline; Dementia; Memory loss

Indexed keywords

APOLIPOPROTEIN E4; NOOTROPIC AGENT;

ALZHEIMER DISEASE; COGNITIVE DEFECT; DEMENTIA; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; DISEASE SEVERITY; EARLY DIAGNOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; REVIEW;

EID: 0033302352     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-1999-14-506     Document Type: Review

References (104)

1. Statement on use of Apolipoprotein E testing for Alzheimer Disease
2. A new definition of Alzheimer's disease: A hippocampal dementia
3. The natural history of Alzheimer's disease. Description of study cohort and accuracy of diagnosis
4. Posterior cortical atrophy
5. Does Alzheimer's disease represent an exaggeration of normal aging?
6. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: Relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype
7. The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective
8. Alpha-2 macroglobulin is genetically associated with Alzheimer disease
9. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects
10. Memory complaints in older adults. Fact or fiction?
11. Progression of dementia in patients with isolated memory loss
12. Asymmetric cortical degenerative syndromes: Clinical and radiologic correlations
13. CERAD Behavior Rating Scale for dementia (BRSD)
14. The reversible dementia: Do they reverse?
15. The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD Study. Consortium to Establish a Registry for Alzheimer's Disease
16. Agitated behaviors in the elderly. I. A conceptual review
17. Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease
18. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimeris disease in late onset families
19. Memory function in normal aging
20. Age-associated memory impairment: Proposed diagnostic criteria and measures of clinical change-report of a National Institute of Mental Health Work Group
21. Biopsy-proved Alzheimer's disease presenting as a right parietal lobe syndrome
22. Characterization of the AD7C-NTP cDNA expression in Alzheimer's disease and measurement of a 41-kD protein in cerebrospinal fluid
23. Increased levels of neuronal thread protein in cerebrospinal fluid of patients with Alzheimer's disease
24. Neuropsychological testing and assessment scales for dementia of the Alzheimer's type
25. If we live long enough, will we all be demented?
26. The prognosis in Alzheimer's disease. 'How far' rather than 'how fast' best predicts the course
27. Psychotic symptoms and the longitudinal course of senile dementia of the Alzheimer type
28. Aphasia in senile dementia of the Alzheimer type
29. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer Disease: A meta-analysis
30. 'Mini Mental State': A Practical method of grading cognitive state of patients for the clinician
31. Visualization and quantification of rates of atrophy in Alzheimer's disease
32. Linear measures of atrophy in mild Alzheimer's disease
33. High cerebrospinal fluid tau and low amyloid B42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype
34. The Consortium to establish a registry for Alzheimer's disease (CERAD) Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease
35. Segregation of a missense mutation in the amyloid precursor gene with Familial Alzheimer Disease
36. Progressive aphasia: A precursor of global dementia?
37. Subjective memory complaints and personality traits in normal elderly subjects
38. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). IX. A prospective cliniconeuropathologic study of Parkinson's features in Alzheimer's disease
39. Association of missense and 5'sokuce-site mutations in tau with the inherited dementia FTDP-17
40. Medial temporal atrophy on MRI in no normal aging and very mild Alzheimer's disease
41. Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's Disease
42. Amyloid B-protein deposition in tissues other than brain in Alzheimer's disease
43. Assessment of cognitive decline in the elderly by informant interview
44. Lewy body disease and dementia
45. Longitudinal study of cerebrospinal fluid levels of tau, Aβ1-40, and Aβ1-42(43) in Alzheimer's Disease: A study in Japan
46. Drop the Alzheimer's drop test
47. Validation of a short Orientation-Memory-Concentration Test of cognitive impairment
48. Substantia nigra lesions in Alzheimer's disease and normal aging
49. Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease
50. Dementia lacking distinctive histologic features: A common non-Alzheimer degenerative dementia
51. Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer's disease: A CERAD analysis
52. Frontotemporal dementias: A new clinical syndrome?
53. Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: An MRI study
54. MRI of the hippocampus in Alzheimer's disease: Sensitivity, specificity, and analysis of the incorrectly classified subjects
55. Age-associated memory impairment: Sorting out the controversies
56. The site of the earliest lesions of Alzheimer's disease
57. The utility of the apoplipoprotein genotype in the diagnosis of Alzheimer's Disease
58. Heterogeneity in dementia of the Alzheimer type: Evidence of subgroups
59. Neuroleptic sensitivity in patients with senile dementia of Lewy body type
60. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lew bodies (DLB): Report of the consortium on DLB international workshop
61. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
62. Consensus statement on predictive testing for Alzheimer disease
63. Neuropathologic assessment of Alzheimer's disease
64. Clinical dementia rating: A reliable and valid diagnostic and staging measure for dementia of the Alzheimer type
65. Clinical Dementia Rating (CDR): Current version and scoring rules
66. The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease
67. The consortium to establish a registry for Alzheimer's disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease
68. Validation of clinical diagnostic criteria for Alzheimer's disease
69. Very mild Alzheimer's disease: Informant-clinical, psychometric, and pathologic distinction from normal aging
70. Senile dementia of the Alzheimer type: An important risk factor for serious falls
71. Cerebral amyloid deposition and diffuse plaques in 'normal' aging: Evidence for presymptomatic and very mild Alzheimer's disease
72. Reduction of beta-amyloid peptide 42 in the cerebrospinal fluid of patients with Alzheimer's disease
73. Alzheimer's disease and apolipoprotein E in an Amish population
74. The clinical introduction of genetic testing for Alzheimer disease
75. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease
76. Is early-onset Alzheimer disease a distinct subgroup within the Alzheimer Disease population?
77. The Global Deterioration Scale for assessment of primary degenerative dementia
78. Familial Alzheimer's disease in kindreds with missense mutations in a novel gene on chromosome 1 related to the Alzheimer's Disease type 3 gene
79. Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity
80. Advanced Alzheimer's disease is a risk factor for late-onset seizures
81. The association of clinical and neurological findings and its bearing on the classification and etiology of Alzheimer's disease
82. A standardized instrument for the diagnosis of mental disorder in the elderly and special reference to the early detection of dementia
83. A potential noninvasive neurobiological tests for Alzheimer's disease
84. Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease
85. A comparison of clinical features in early-and late-onset primary degenerative dementia
86. Age at disease onset and pattern of cognitive impairment in probable Alzheimer's disease
87. Cloning of a gene bearing missense mutations in early onset familial Alzheimer's disease
88. Diagnosis and treatment of Alzheimer Disease and related disorder: Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association and the American Geriatrics Society
89. Very mild senile dementia of the Alzheimer type II. psychometric test performance
90. Pathologic changes in olfactory neurons of Alzheimer's disease
91. Amyloid b-protein 42(43) in the cerebrospinal fluid of patients with Alzheimer's disease
92. Consensus report of the working group on molecular and biochemical markers of Alzheimer's Disease
93. Prediction of probable Alzheimer's disease in memory-impaired patients: A prospective longitudinal study
94. The Mini-Mental State Examination: A comprehensive review
95. Survival of outpatients with Alzheimer-type dementia
96. Neuropsychological assessment of Alzheimer's disease
97. Geriatric epidemiology
98. Should we differentiate subtypes of Alzheimer Disease?
99. Genetic studies on chromosome 12 in late-onset Alzheimer disease
100. Longitudinal neuropsychological and quantitative MRI assessments in early Alzheimer's disease
101. Development and validation of a geriatric depression screening scale: A preliminary report